findmyKOL

Matthias Kretzler, MD

Enriched profile

Warner-Lambert/Parke-Davis Professor of Medicine (Internal Medicine/Nephrology and Computational Medicine and Bioinformatics), Research Professor · University of Michigan

ORCIDNPI
Region🇺🇸 Ann Arbor, MI · Midwest · United StatesSpecialtyNephrologyFocusRenal Diseases and Glomerulopathies+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2007–2026

Matthias Kretzler is Warner-Lambert/Parke-Davis Professor of Medicine (Internal Medicine/Nephrology and Computational Medicine and Bioinformatics), Research Professor at University of Michigan. OpenAlex indexes 734 publications with 48,281 citations (h-index 110); ClinicalTrials.gov lists 5 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Nephrology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Matthias Kretzler, MD, is Warner-Lambert/Parke-Davis Professor of Medicine (Internal Medicine/Nephrology and Computational Medicine and Bioinformatics), Research Professor at University of Michigan (Michigan Medicine / University of Michigan Medical School). The public record shows 734 publications with 48,281 citations (h-index 110), centered on Renal Diseases and Glomerulopathies, Chronic Kidney Disease and Diabetes, Renal and related cancers. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 9 companies, 14 NIH-funded awards (2007–2026).

  • Most recent indexed publication: 2026 · Journal of the American Society of Nephrology
  • Top research focus: Renal Diseases and Glomerulopathies
  • 5 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 9 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Chronic Kidney Disease3 trialsGlomerulonephritis, Membranous2 trialsGlomerulosclerosis, Focal Segmental2 trialsNephrosis, Lipoid2 trialsType 1 Diabetes1 trialHeart Failure1 trialGlomerular Disease1 trialNephrotic Syndrome1 trialNephritis, Hereditary1 trialLupus (SLE)

Research focus

OpenAlex concept fingerprint
Renal Diseases and GlomerulopathiesChronic Kidney Disease and DiabetesRenal and related cancersSystemic Lupus Erythematosus ResearchSingle-cell and spatial transcriptomics

Drugs & molecules

across trials, industry payments and publications
Ozempicgeneric · SemaglutideClinical trialsIndustry payments2Publications

Works with

trial sponsors and companies reporting payments
Travere Therapeutics, Inc.Clinical trialsIndustry payments20Regeneron Pharmaceuticals, Inc.Clinical trialsIndustry payments11Otsuka Pharmaceutical Development & Commercialization, Inc.Clinical trialsIndustry payments10

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
734publications

Distinct works indexed by OpenAlex, matched via ORCID; 52 in PubMed.

48,281citations

Total citations across indexed works.

110h-index

Hirsch index (OpenAlex). i10-index 405.

Clinical & industry

trials, payments and federal funding
5clinical trials

Investigator role on registered studies.

View trials
9companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
14NIH grants · 2007–2026

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:

2 more trial records behind the reveal.Reveal →

Industry payments

Updated 27 Aug 2026

9 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2022)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    59.7%
    ACE inhibitor24.7%
    Lisinopril100%
    Part D<11 patients
    Statin20.8%
    Atorvastatin Calcium100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    23.4%
    Proton pump inhibitor23.4%
    Omeprazole100%
    Part D<11 patients
  • Blood & clotting

    16.9%
    Erythropoiesis-stimulating Agent16.9%
    Procrit100%
    Part D<11 patients

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

14 NIH research awards on record, funded 20072026 per NIH RePORTER. The latest:

Congress activity

Updated 27 Aug 2026

10 congress contributions (2018–2025) across ADA, ASH per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/matthias-kretzler-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • LinkedIn

    linkedin.com/in/matthias-kretzler-403a9b31

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com
  • ResearchGate

    researchgate.net/profile/Matthias-Kretzler

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net

Mentions by others

where others cite or feature them
  • Other

    asn-online.org/media/podcast.aspx

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →asn-online.org
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    University of Heidelberg, Germany (MD/PhD-structured program with Wilhelm Kriz's Anatomy and Cell Biology group)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →miktmc.org
  • provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →miktmc.org

Awards & honors

honors on the public record
  • 2026 Homer W. Smith Award

    American Society of Nephrology

    2026
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medschool.umich.edu
  • Elected member

    American Society for Clinical Investigation (ASCI)

    2011
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →the-asci.org

Secondary affiliations

appointments beyond the home institution
  • Co-leader

    NIDDK Kidney Precision Medicine Project (KPMP) Central Hub and Kidney Mapping Atlas Project (KMAP)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →miktmc.org
  • Leader/PI

    Nephrotic Syndrome Research Network (NEPTUNE), NIH Rare Disease Clinical Research Network

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →precisionhealth.umich.edu
  • Principal Investigator

    JDRF Center of Excellence at University of Michigan

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →miktmc.org
5 more affiliations behind the reveal.Reveal →

Media & interviews

press, podcasts and appearances
1 more media item behind the reveal.Reveal →

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.